Hem › Bukspottkörtelcancer › Pennsylvania › Philadelphia
Kliniska studier för Bukspottkörtelcancer i Philadelphia, PA
26 studier för Bukspottkörtelcancer söker deltagare vid platser i och runt Philadelphia (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekryterarFas 3
- Thomas Jefferson University, Philadelphia
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekryterarFas 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
RekryterarObservationsstudie
- Research Site, Philadelphia
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 3
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekryterarFas 3
- Investigative Site US008, Philadelphia
- Investigative Site US043, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekryterarFas 1/2
- Hospital of the University of Pennsylvania, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Rekryterar
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 2
- Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office, Philadelphia
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RekryterarObservationsstudie
- Children's Hospital of Philadelphia, Philadelphia
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekryterarObservationsstudie
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- och 5 fler
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekryterarFas 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi bort
- och 1 fler
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Investigative Site #109, Philadelphia
Pancreatic Cancer Early Detection Consortium
RekryterarObservationsstudieFriska volontärer välkomna
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekryterarFas 1
- Sidney Kimmel Cancer Center, Philadelphia
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RekryterarFas 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi bort
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi bort
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekryterarFas 1/2
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Collection of Circulating Biomarkers in Pancreatic Cancer
RekryterarObservationsstudie
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
RekryterarFas 2
- Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekryterarFas 1/2
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- University of Pennsylvania, Philadelphia
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekryterarFas 2
- Ohio State University-Telemedicine, Philadelphia
- Ohio State University-Telemedicine, Wilmington · 25 mi bort
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
RekryterarObservationsstudie
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
FTT PET/CT in Pancreatic Neuroendocrine Tumors
RekryterarFas 1
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RekryterarObservationsstudie
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi bort
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekryterarFas 3
- University of Pennsylvania, Philadelphia
Bukspottkörtelcancer-studier i andra städer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Tampa, FL26 studier
- Durham, NC24 studier
- San Diego, CA24 studier
Andra studier i Philadelphia
- Cancer (alla typer)59 studier
- Bröstcancer56 studier
- Icke-småcellig lungcancer51 studier
- Metastaserande cancer46 studier
- Prostatacancer44 studier
- Kolorektal cancer44 studier
- Äggstockscancer44 studier
- Lungcancer36 studier
- Akut myeloid leukemi34 studier
- Hjärtsvikt31 studier
- Endometriecancer28 studier
- Depression26 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.